News release
From:
Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Journal/
conference: PLOS ONE
conference: PLOS ONE
Research:Paper
Organisation/s:
Karolinska Institutet (Sweden), Hospital Clinic de Barcelona (Spain), Astrid Lindgren Children’s Hospital, Karolinska University Hospital, University of North Carolina at Chapel Hill, Indiana University, Shire Sweden AB, a Takeda Company (Sweden), Global Medical Affairs, Shire International GmbH, a Takeda Company (Switzerland), Orebro University (Sweden)
Funder:
This study received funding from the Swedish Research Council (Vetenskapsrådet, award: 2018-02599), and through a grant from Shire International GmbH, a member of Takeda group of companies, Zug, Switzerland. Dr. Bulik acknowledges funding from the Swedish Research Council (award: 538-2013-8864). Although the sponsor (Shire) was involved in the design, collection, analysis, interpretation of the data, and writing of the report, the content of this manuscript, the ultimate interpretation, and the decision to submit it for publication in PlosOne was made by the authors independently.